Guidance for the diagnosis and treatment of hypolipidemia disorders.
Bredefeld C, Hussain MM, Averna M, Black DD, Brin MF, Burnett JR, Charrière S, Cuerq C, Davidson NO, Deckelbaum RJ, Goldberg IJ, Granot E, Hegele RA, Ishibashi S, Karmally W, Levy E, Moulin P, Okazaki H, Poinsot P, Rader DJ, Takahashi M, Tarugi P, Traber MG, Di Filippo M, Peretti N.
J Clin Lipidol. 2022 Nov-Dec;16(6):797-812. doi: 10.1016/j.jacl.2022.08.009. Epub 2022 Sep 29.
Hypotriglyceridemias/hypolipidemias.
Martínez-Hervás S, Real-Collado JT, Ascaso-Gimilio JF.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:63-68. doi: 10.1016/j.arteri.2020.12.011.
Commentary.
Remaley AT.
Clin Chem. 2012 May;58(5):830. doi: 10.1373/clinchem.2012.182147.
Hypocholesterolemia.
Moutzouri E, Elisaf M, Liberopoulos EN.
Curr Vasc Pharmacol. 2011 Mar;9(2):200-12. doi: 10.2174/157016111794519354.
Low LDL cholesterol-Friend or foe?
Hartz J, Hegele RA, Wilson DP.
J Clin Lipidol. 2019 May-Jun;13(3):367-373. doi: 10.1016/j.jacl.2019.05.006. Epub 2019 May 16.
Neuroacanthocytosis syndromes.
Jung HH, Danek A, Walker RH.
Orphanet J Rare Dis. 2011 Oct 25;6:68. doi: 10.1186/1750-1172-6-68.
Low cholesterol states: clinical implications and management.
Gill PK, Hegele RA.
Expert Rev Endocrinol Metab. 2023 May;18(3):241-253. doi: 10.1080/17446651.2023.2204932. Epub 2023 Apr 23.
[Neuroacanthocytosis update].
Ichiba M, Nakamura M, Sano A.
Brain Nerve. 2008 Jun;60(6):635-41.
Update on primary hypobetalipoproteinemia.
Hooper AJ, Burnett JR.
Curr Atheroscler Rep. 2014 Jul;16(7):423. doi: 10.1007/s11883-014-0423-3.
Hypolipidemia.
Malloy MJ, Kane JP.
Med Clin North Am. 1982 Mar;66(2):469-84. doi: 10.1016/s0025-7125(16)31431-6.
